ArticleCardiovascular drugs and therapy2026

Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients.

Shriya Chunduri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.